Ophthalmic compositions for treating ocular hypertension

Details for Australian Patent Application No. 2003287506 (hide)

International Classifications

Event Publications

1 April 2004 Complete Application Filed

Priority application(s): 60/500,091 04.09.03 US; 60/424,808 08.11.02 US

8 July 2004 Application Open to Public Inspection

Published as AU-B-2003287506

23 April 2009 Application Accepted

Published as AU-B-2003287506

28 May 2009 Corrigenda

Applications Accepted - Name Index Under the name Merck & Co., Inc., Application No. 2003287506, under INID(72) correct the co-inventor to Doherty, James B.

20 August 2009 Standard Patent Sealed

21 January 2010 Amendment Made

The nature of the amendment is: Amend patentee name from Merck & Co., Inc. to Merck Sharp & Dohme Corp.

11 October 2012 Alteration of Name

The name of the patentee has been altered to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.